PharmiWeb.com - Global Pharma News & Resources
13-Dec-2018

Blood Coagulation Factor Activators Pipeline Insights Report 2018 - ResearchAndMarkets.com

The "Blood Coagulation Factor Activators -Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.

'Blood Coagulation Factor Activators - Pipeline Insight, 2018' report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Blood Coagulation Factor Activators development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Descriptive coverage of pipeline development activities for Blood Coagulation Factor Activators - Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Key Topics Covered:

1. Report Introduction

2. Blood Coagulation Factor Activators - Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Blood Coagulation Factor Activators

4. Comparative Analysis

5. Blood Coagulation Factor Activators Pipeline Products in Clinical Stages

  • Product Description
  • Research and Development
  • Product Development Activities

6. Blood Coagulation Factor Activators Pipeline Products in Non-clinical Stages

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment: Active Products

  • Pipeline Assessment by Route of Administration
  • Pipeline Assessment by Stage and Route of Administration
  • Pipeline Assessment by Molecule Type
  • Pipeline Assessment by Stage and Molecule Type

8. Inactive Pipeline Products

  • Product Description
  • Research and Development
  • Product Development Activities
  • Reason for dormancy/discontinuation

Companies Mentioned

  • Catalyst Biosciences
  • Bioverativ
  • XL-protein GmbH
  • Biotest AG
  • Amsterdam Molecular Therapeutic
  • Pfizer
  • Octapharma

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/8b5bs9/blood_coagulation?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181213005883/en/

Editor Details

Last Updated: 13-Dec-2018